Location: Boston, MA
CIK: 0001346824 · Show all filings
Period: Q4 2015 (← Previous) (Next →)
Filing Date: Feb 16, 2016
Total Value: $1.011B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ACHILLION PHARMACEUTICALS INC | 11,222,893 | $121M | 12.0% | $6.36 | — | COM | 00448Q201 |
| WVE | WAVE LIFE SCIENCES LTD | 7,088,651 | $113M | 11.2% | $15.68 | 0.0% | SHS | Y95308105 |
| — | DYAX CORP | 2,717,618 | $102M | 10.1% | $10.04 | — | COM | 26746E103 |
| — | AXOVANT SCIENCES LTD | 5,000,000 | $90.15M | 8.9% | $20.38 | — | COM | G0750W104 |
| ACRS | ACLARIS THERAPEUTICS INC | 2,564,553 | $69.09M | 6.8% | $19.34 | 0.0% | COM | 00461U105 |
| TGTX | TG THERAPEUTICS INC | 2,813,779 | $33.57M | 3.3% | $10.99 | +15.0% | COM | 88322Q108 |
| — | ZOGENIX INC | 2,253,237 | $33.21M | 3.3% | $13.82 | — | COM NEW | 98978L204 |
| BCRX | BIOCRYST PHARMACEUTICALS | 3,094,064 | $31.93M | 3.2% | $9.58 | +3.8% | COM | 09058V103 |
| ASND | ASCENDIS PHARMA A S | 1,671,447 | $30.62M | 3.0% | $17.61 | — | SPONSORED ADR | 04351P101 |
| — | REGULUS THERAPEUTICS INC | 3,482,924 | $30.37M | 3.0% | $15.20 | — | COM | 75915K101 |
| CHRS | COHERUS BIOSCIENCES INC | 1,272,048 | $29.21M | 2.9% | $14.11 | +82.4% | COM | 19249H103 |
| — | DICERNA PHARMACEUTICALS INC | 2,428,571 | $28.83M | 2.9% | $28.25 | — | COM | 253031108 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 857,683 | $23.59M | 2.3% | $17.29 | +21.8% | COM | 19459J104 |
| — | BLUEPRINT MEDICINES CORP | 878,348 | $23.14M | 2.3% | $26.49 | — | COM | 09627Y109 |
| — | PROTEON THERAPEUTICS INC | 1,476,931 | $22.91M | 2.3% | $11.67 | — | COM | 74371L109 |
| — | STRONGBRIDGE BIOPHARMA PLC | 2,690,702 | $20.45M | 2.0% | $7.60 | — | SHS USD | G85347105 |
| — | AQUINOX PHARMACEUTICALS INC | 1,619,977 | $20.22M | 2.0% | $13.98 | — | COM | 03842B101 |
| SGMO | SANGAMO BIOSCIENCES INC | 2,212,036 | $20.2M | 2.0% | $8.61 | -10.5% | COM | 800677106 |
| — | CIDARA THERAPEUTICS INC | 1,174,219 | $20.15M | 2.0% | $13.98 | — | COM | 171757107 |
| — | ALCOBRA LTD | 3,032,911 | $19.05M | 1.9% | $6.39 | — | SHS | M2239P109 |
| — | ARENA PHARMACEUTICAL S INC | 8,714,482 | $16.56M | 1.6% | $1.90 | — | COM | 040047102 |
| — | GLOBAL BLOOD THERAPEUTICS INC | 457,142 | $14.78M | 1.5% | $42.16 | — | COM | 37890U108 |
| — | AIMMUNE THERAPEUTICS INC | 790,200 | $14.58M | 1.4% | $25.32 | — | COM | 00900T107 |
| — | DIMENSION THERAPEUTICS INC | 1,087,930 | $12.27M | 1.2% | $11.28 | — | COM | 25433V105 |
| ARDX | ARDELYX INC | 571,444 | $10.36M | 1.0% | $12.61 | +47.7% | COM | 039697107 |
| — | PRONAI THERAPEUTICS INC | 604,982 | $9.099M | 0.9% | $20.52 | — | COM | 74346L101 |
| NTRA | NATERA INC | 783,520 | $8.462M | 0.8% | $16.90 | -43.7% | COM | 632307104 |
| — | TENAX THERAPEUTICS INC | 2,389,700 | $7.838M | 0.8% | $3.92 | — | COM | 88032L100 |
| — | VITAE PHARMACEUTICALS INC | 321,161 | $5.813M | 0.6% | $11.01 | — | COM | 92847N103 |
| — | ZYNERBA PHARMACEUTICALS INC | 507,191 | $5.107M | 0.5% | $14.31 | — | COM | 98986X109 |
| — | APPLIED GENETIC TECHNOL CORP | 236,059 | $4.816M | 0.5% | $16.68 | — | COM | 03820J100 |
| — | NIVALIS THERAPEUTICS INC | 612,863 | $4.744M | 0.5% | $15.15 | — | COM | 65481J109 |
| — | AKARI THERAPEUTICS PLC | 263,921 | $3.827M | 0.4% | $24.00 | — | SPONSORED ADR | 00972G108 |
| — | ARCA BIOPHARMA INC | 778,211 | $3.619M | 0.4% | $4.96 | — | COM PAR$.001 | 00211Y407 |
| — | DERMA SCIENCES INC | 641,236 | $2.93M | 0.3% | $4.57 | — | COM PAR $.01 | 249827502 |
| — | NEURODERM LTD | 144,671 | $2.467M | 0.2% | $20.67 | — | ORD SHS | M74231107 |
| — | AMPLIPHI BIOSCIENCES CORP | 53,600 | $213K | 0.0% | $3.95 | — | COM NEW | 03211P202 |